Delivery Order SPE2DB24D1021-SPE2DB25FEYQF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Diovan HCT 160-12.5 mg tablets (90-count) with a ceiling value of $17,047.43. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is due for completion by August 13, 2025. The award was executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.50 to AmerisourceBergen Drug Corp for Diovan HCT 160-25 mg tablets (90-count supply) on August 15, 2025, with completion scheduled for August 18, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Diovan HCT 160-12.5 mg tablets (90 count) with a contract value of $2,386.06. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Diovan HCT 160-25 mg tablets (90 count) with a ceiling value of $1,038.57. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is scheduled for completion by August 11, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a task...
- The Defense Logistics Agency awarded a delivery order valued at $97,006.28 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-25 mg tablets (90-count) under a firm fixed price contract. The award, issued on July 23, 2025, with completion by July 24, 2025, represents a competitive procurement with no set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $20,575.76 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-12.5 mg tablets (90-count) under a firm fixed price arrangement. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and is classified as a non-set-aside competitive procurement. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Diovan HCT 320-12.5 mg tablets (90-count units) with a ceiling value of $2,560.36 and an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-12.5 mg tablets (90-count) valued at $20,722.73 under a firm fixed-price contract with an ultimate completion date of August 26, 2025. The award, issued on August 25, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Diovan HCT 320-12.5 mg tablets in quantities of 90 units, with a firm fixed price ceiling value of $7,529.56. The contract represents a non-competitive, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. Performance will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,090.39 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Diovan HCT 80-12.5 mg tablets (90-count bottles). This competitive award, issued without set-aside designation, utilizes firm fixed pricing and is scheduled for completion by August 19, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYQFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,802.24 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-25 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order was issued on July 14, 2025, with an ultimate completion date of July 15, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, leverages this comprehensive global pharmaceutical support vehicle to supply a broad range of medications, medical supplies, and healthcare commodities to support military healthcare programs and other federal customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order represents a routine pharmaceutical procurement in support of federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 7/14/25 |